Search

Xanthelasma

Although the lesion known as Xanthelasma was first described by Addison and Gall in 1851 [1] it was recorded some 300 years previously in the famous painting of the Mona Lisa by Leonardo da Vinci. In this painting, Leonardo da...

Off-label cosmetic use of botulinum toxin in the lower face

Botulinum toxin A (BoNTA) is commonly used as an off-label cosmetic modality to improve the ageing lower face and neck, and may be used as a single line treatment or in combination with other procedures, such as dermal fillers [1]....

Response to the Keogh Review

On 13 February 2014 the UK Government published its response to the Keogh Review of the regulation of cosmetic interventions (https://www.gov.uk/government/publications/regulation-of-cosmetic-interventions-government-response). This response has been much anticipated by the fields of plastic surgery and aesthetic medicine and inevitably has provoked...

MD/PhDs or MD/MBAs: which do we need more to innovate in plastic surgery?

I would like to thank Arlen Meyers and Victor Castro for submitting this article. One of the problems that I have seen in my professional lifetime is the failure of entrepreneurs to grasp that there is no infinite health care...

Melanoma skin cancer: how can we improve early detection in the UK?

With melanoma rates increasing globally, should there be screening of high-risk groups? Stephen Hayes takes a look at how Australia has reduced its melanoma mortality and asks whether a similar model should be adopted elsewhere. In Britain, some 16,000 new...